Our bodies are constantly deciding which cells should live and which should die through a process called apoptosis. This type ...

Novartis is buying Myricx to internalize an NMTi-based ADC payload platform intended to expand ADC applicability and ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

The new facility will enable cancer patients to take part in tailored and supervised exercise programmes, a key tool for improving their physical and emotional well-being and their tolerance of treatm ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...

Key Takeaways. Caregiver fear and availability meaningfully influence patient willingness to pursue CAR T and other immune effector therapies, contributing to persistently low uti ...

AI has the potential to help bring predictability to complicated workflows by standardizing the path from simulation to ...

University of Tasmania professor Andrew Files says devils have a mutated gene that might make the carnivorous marsupial more ...

Novocure has received the CE mark for Optune Pax, its portable medical device intended to treat adults with locally advanced ...

As artificial intelligence (AI) rapidly becomes part of everyday life, one question continues to dominate conversations across healthcare: Can AI replace docto ...